BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11186865)

  • 1. Sustained remission of CMV retinitis in HIV-2 disease.
    Papadopoulou VI; Shah SM
    Br J Ophthalmol; 2000 Dec; 84(12):1437. PubMed ID: 11186865
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs for treating CMV. Valcyte, an oral compound, expands the treatment options for people with CMV retinitis.
    Eagan L
    Posit Living; 2001; 10(6):13. PubMed ID: 11702748
    [No Abstract]   [Full Text] [Related]  

  • 3. Corneal infiltration and CMV retinitis in a patient with AIDS.
    Inoue T; Hayashi K; Omoto T; Kosaki R; Higaki S; Shimomura Y
    Cornea; 1998 Jul; 17(4):441-2. PubMed ID: 9676918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subretinal hemorrhage in cytomegalovirus.
    Dornic D; Vann V; Wyszynski R
    Retina; 1998; 18(1):73-5. PubMed ID: 9502287
    [No Abstract]   [Full Text] [Related]  

  • 5. Subretinal hemorrhage associated with cytomegalovirus retinitis in a patient without concurrent thrombocytopenia.
    Beck AP; Ravage ZB; Richmond CA
    Retina; 2004 Aug; 24(4):611-3. PubMed ID: 15300084
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.
    Hassan-Moosa R; Chinappa T; Jeena L; Visser L; Naidoo K
    S Afr Med J; 2017 Sep; 107(10):843-846. PubMed ID: 29022526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.
    Akula SK; Ma PE; Peyman GA; Rahimy MH; Hyslop NE; Janney A; Ashton P
    Br J Ophthalmol; 1994 Sep; 78(9):677-80. PubMed ID: 7947546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New treatment options for CMV retinitis in AIDS.
    Lalezari JP
    Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
    Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR
    AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of ganciclovir implants for CMV retinitis in an 18-month-old child with AIDS.
    Dalton R; Aylward GW; Sharland M
    Eye (Lond); 1999; 13 ( Pt 1)():110-2. PubMed ID: 10396395
    [No Abstract]   [Full Text] [Related]  

  • 11. CMV trial enrolling.
    Vazquez E
    Posit Aware; 1997; 8(4):13. PubMed ID: 11364480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 13. Cystoid macular edema due to cytomegalovirus retinitis in a patient with acquired immune deficiency syndrome.
    Weinberg DV; Moorthy RS
    Retina; 1996; 16(4):343-4. PubMed ID: 8865398
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytomegalovirus polyradiculopathy caused by a ganciclovir-resistant strain.
    Tokumoto JI; Hollander H
    Clin Infect Dis; 1993 Nov; 17(5):854-6. PubMed ID: 8286625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA approves oral ganciclovir as first drug to prevent CMV disease. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local therapy of CMV retinitis: a new therapeutical approach.
    Fuchs AV; Scheider A; Klauss V; Kampik A
    Dev Ophthalmol; 1997; 29():64-8. PubMed ID: 9413696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prophylaxis secondary to retinitis by CMV in patients with AIDS: the efficacy of an intermittent schedule of 3 days/week].
    Mallolas J; Gatell JM; Gómez-Sirvent JL; Buira E; Zamora L; Alecrim-Andrade J; Adán A; Morales M; Miró JM; Lonća M; Guelar A; Soriano E
    Enferm Infecc Microbiol Clin; 1997 Feb; 15(2):61-4. PubMed ID: 9101748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular manifestations of AIDS.
    Whitcup SM
    JAMA; 1996 Jan; 275(2):142-4. PubMed ID: 8531310
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytomegalovirus retinitis in AIDS patients: a comparative study of intravenous and oral ganciclovir as maintenance therapy.
    Danner SA; Matheron S
    AIDS; 1996 Dec; 10 Suppl 4():S7-11. PubMed ID: 9110064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.